Astagen

Quick links to important sections

Astagen

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Astagen

Quick Facts

Property Description
Active ingredient Salbutamol (Salbutamol Sulfate / Albuterol)
Form Metered-Dose Aerosol, Solution (Inhalation), Tablets, Syrup
Pharmacological class Selective beta2 Adrenergic Receptor Agonist (SABA)
Common purpose Rapid relief of airflow limitation
Origin Synthetic

What is Astagen and What Type of Medicine Is It?

Astagen is a synthetic pharmaceutical preparation containing the active ingredient Salbutamol, often formulated as Salbutamol Sulfate. This substance is also known by the generic name Albuterol. The medication is classified as a Selective beta2 Adrenergic Receptor Agonist, which categorizes it as a bronchodilator.

Salbutamol is a single-ingredient compound that functions as a Short-acting beta2-agonist (SABA). This chemical is produced as a racemic mixture, which signifies its synthetic origin. As a SABA, it is characterized as a rescue medication intended for immediate action rather than long-term maintenance.


How is Astagen Formulated and What is its Purpose?

Astagen is available in several dosage forms intended for specific delivery methods. These include metered-dose aerosols and respiratory solutions for inhalation, as well as tablets and syrup for oral administration. Inhaled formulations utilize Salbutamol Sulfate integrated into a propellant system or an aqueous base for nebulization. These various formats allow for administration across different patient needs.

The primary purpose of this medication is to provide relief from symptoms caused by narrowed air passages. Its pharmacological action involves the relaxation of airway smooth muscle. This mechanism results in bronchodilation—the widening of the airways—which assists in restoring airflow and easing acute breathlessness.

What side effects are possible with Astagen?

Possible Side Effects and Safety Information

The safety profile for Astagen is derived exclusively from official government regulatory documentation, outlining known adverse reactions and necessary precautions.

Adverse Reactions

The most frequently reported adverse reactions are generally mild and affect the gastrointestinal system, classified as Common. These include:

  • Increased frequency of bowel movements
  • Red-colored stool

Less frequently reported gastrointestinal effects may include nausea, constipation, vomiting, and stomach pain, with stomach pain noted specifically in regulatory documents as a potential effect when using high doses.

Adverse reactions involving the skin and subcutaneous tissue have been reported, such as itching, rash, pruritus, urticaria, and angioedema.

Serious Adverse Reactions

The official safety documents note the potential for serious hypersensitivity (allergic) reactions. Signs of a serious allergic reaction may include difficulty breathing, severe itching, or a pronounced rash, requiring immediate medical attention.

Safety Restrictions and Considerations

Astagen is not recommended for use in individuals with a known hypersensitivity to any component of the product. The official safety profile also includes the following limitations:

  • Population Data: There is currently insufficient reliable safety data documented in regulatory sources regarding the use of Astagen in individuals who are pregnant, breastfeeding, or in young children.
  • Drug Interactions: Caution is advised due to the potential for Astagen to interact with several types of medication, including those that affect blood clotting (anticoagulants), blood pressure (antihypertensives), and the immune system (immunosuppressants). Regulatory sources also note the potential for interaction with certain liver enzyme substrates (CYP2B6 and CYP3A4).

Overdose and Emergency Response

Overdose of Astagen (Salbutamol/Albuterol) is defined in regulatory labeling by severe manifestations linked to excessive beta-adrenergic stimulation. The documented clinical presentation includes pronounced symptoms such as tachycardia (rapid heart rate), tremor, nervousness, palpitations, and sometimes headache or dizziness. Life-threatening consequences have been reported in association with excessive use, including cardiac arrest and serious arrhythmias.

The regulatory profile emphasizes significant metabolic disturbances, notably a potentially serious drop in serum potassium, known as hypokalemia, as well as lactic acidosis and hyperglycemia. In certain patient populations, such as children receiving oral overdose, specific findings like hyperglycemia are documented.

Immediate medical attention is required for any suspected overdose. Government guidance explicitly states that emergency medical services must be contacted immediately for symptoms indicating a severe event, such as collapse, seizures, or profound respiratory distress. If paradoxical bronchospasm occurs, the medicine must be discontinued immediately.

Management, which must be supervised by a medical professional, is supportive, often involving the required monitoring of heart activity and serum potassium levels. Beta-receptor blocking agents may be considered, but their use is cautioned against due to the documented risk of inducing severe bronchospasm.

Therapeutic Uses of Astagen

Quick Facts: Astagen Uses

  • Helps prevent the body from rejecting a transplanted organ (kidney, liver, or heart).
  • Supports the management of severe active rheumatoid arthritis in certain adults.
  • Assists in controlling symptoms of severe plaque psoriasis in specific adult patients.

What Astagen Treats: Main Uses and Benefits

Astagen is an important component of a comprehensive medical regimen, primarily indicated to help manage the immune system's response to an allogeneic organ transplant, such as a transplanted kidney, liver, or heart. By working to modulate the body's natural defenses, Astagen supports the ability to prevent organ rejection.

For specific individuals, Astagen may be used for the management of certain autoimmune conditions. It is indicated for assisting in the control of severe active rheumatoid arthritis in patients whose condition has not adequately responded to other treatments, such as methotrexate. It can also contribute to lessening the severity of symptoms associated with severe plaque psoriasis in adult patients who have failed to respond to at least one other type of systemic therapy. These uses help patients to improve their overall quality of life when used under the guidance of a healthcare provider.

Regulatory References

  1. FDA professional prescribing information for immunosuppressive agents

Eligibility and Restrictions for Use

Astagen is typically prescribed for specific conditions, and its suitability depends on an individual's overall health and medical history. As with any medication, certain patient groups are generally advised not to use Astagen due to potential risks or interactions.

Who Can Use Astagen?

Astagen is generally indicated for adult patients with the specific conditions it is approved to treat. Use is determined after a thorough medical evaluation by a healthcare provider who assesses the risk-benefit profile for the individual.

Group Condition
Adults As prescribed for approved indications
Specific Patient Populations At the discretion of a specialist, based on risk assessment

Who Cannot Use Astagen? (Contraindications)

Astagen is generally contraindicated for several groups. Do not use Astagen if you have a known hypersensitivity or allergic reaction to the drug or any of its inactive ingredients.

Contraindications often include, but may not be limited to:

  • Pregnant or Breastfeeding Women: Due to potential harm to the fetus or infant.
  • Patients with Severe Hepatic Impairment: The drug's metabolism may be significantly affected.
  • Individuals with Certain Pre-existing Conditions: Such as specific uncontrolled cardiovascular diseases or active internal bleeding, depending on Astagen’s specific drug class.

Always disclose your complete medical history and all current medications, including over-the-counter drugs and supplements, to your healthcare provider before starting Astagen. Your doctor is the only source who can determine if this medication is safe for you.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Astagen (Astaxanthin) defines its interaction profile based on effects on hemostasis and absorption.

Pharmacodynamic Interaction Constraints

The primary constraint is a Pharmacodynamic (PD) interaction involving agents that affect blood clotting. Official documentation states that co-administration with blood-thinning agents (such as Warfarin or Aspirin) and NSAIDs (such as Ibuprofen or Naproxen) may increase the risk of bleeding or hemorrhage due to potential additive effects on blood hemostasis. Caution and monitoring are required with these combinations.

Pharmacokinetic Interaction Constraints

A Pharmacokinetic (PK) interaction is documented with specific substances that reduce the drug's systemic exposure. Cholestyramine, Colestipol, Mineral oil, and Orlistat are listed as agents that may reduce the absorption rate of Astagen in the gastrointestinal tract, potentially leading to lower levels in the body.

Classification Interacting Agents / Category Regulatory Statement Basis
PD Risk Blood-thinning agents, NSAIDs Increased risk of bleeding/hemorrhage
PK Reduction Absorption Reducers Decreased absorption rate of Astagen

Other Documented Interactions

Astagen's use is officially contraindicated in individuals with known allergies or hypersensitivity to Astaxanthin or any component of the formulation. Furthermore, regulatory warnings note potential interactions with alcohol and specific hormonal herb supplements and certain carotenoid-rich or high-calcium foods.

Mechanism of Action

Astagen contains astaxanthin, a lipophilic carotenoid that integrates into the cell and mitochondrial membranes due to its polar-nonpolar-polar structure. This permits its direct interaction with lipid bilayers, where it functions as a potent scavenger of reactive oxygen species (ROS), including singlet oxygen (^1O2), and inhibits lipid peroxidation (LPO).

Intracellularly, astaxanthin acts as an activator of the nuclear factor erythroid 2-related factor 2 (Nrf2) transcription factor. Activation promotes Nrf2 nuclear translocation and binding to the antioxidant response element (ARE) within gene promoters. This leads to the transcriptional upregulation of phase II detoxification and antioxidant enzymes, such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), enhancing the endogenous cellular antioxidant capacity.

Furthermore, the compound modulates inflammatory signaling by acting as an inhibitor of the nuclear factor kappa-B (NF-kappaB) pathway. It suppresses the phosphorylation and nuclear translocation of NF-kappaB, consequently downregulating the gene expression and secretion of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha) and interleukins (IL-1beta, IL-6). The combined molecular and cellular effects result in system-level modulation of oxidative and inflammatory processes across multiple tissues, including neural and cardiovascular systems.

Dosage and Administration Information

How Astagen is Used: Official Administration Guidelines

Astagen is administered via the oral route, available as soft gelatin capsules and solution, and as an intravenous (IV) injection for temporary use when oral intake is not feasible.

Dosing and Frequency

Dosage is determined by the prescriber based on the patient's body weight (mg/kg), beginning with an initial regimen that is gradually titrated down to a lower long-term maintenance dose. The medicine is generally scheduled for administration twice daily (BID). For patients who require the intravenous injection, the dose is lower than the oral dose and must be administered as a slow infusion over a period of two to six hours.

Administration and Monitoring Requirements

A critical requirement for proper use is that the oral dosage must be taken consistently with respect to food every day to maintain a stable concentration in the body. The different oral formulations (e.g., modified vs. non-modified) are not interchangeable and require strict supervision and reassessment upon any switch. The dosage is not fixed; adjustments are made based on the results of routine therapeutic drug monitoring (TDM), specifically by measuring drug trough blood concentrations.

Population Rules and Procedural Structure

The usage protocol establishes that pediatric patients may require and tolerate a higher mg/kg dose than adults due to faster drug clearance. Overall, the administration protocol is highly procedural, mandating that the weight-based dose, BID frequency, and necessary preparation steps (such as IV dilution) are meticulously followed. This structure ensures a controlled and standardized approach to the drug's use.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Astagen

This section provides an overview of the types of scientific research conducted on Astagen (salbutamol) and the patterns described in official and peer-reviewed scientific literature. It focuses on how studies are designed, what they monitor, and where research remains limited, without offering any clinical advice.

Evidence for Use in Acute Airflow Obstruction and Bronchospasm

Research has primarily focused on the quick, short-term use of Astagen in conditions characterized by fluctuating or episodic manifestations of breathing difficulties. The primary method involves short-term Randomized Controlled Trials (RCTs) where individuals are studied for the outcomes reflecting daily functioning or activity level over defined time intervals, such as the timeframe over which a measurable change occurs in lung airflow. The findings describe patterns observed in the studies where a measurable change in lung function was observed in the minutes immediately following administration. Systematic reviews of these high-level summaries studies monitored how patient-reported outcomes describing perceived discomfort, such as wheezing and breathlessness, were studied for a change in intensity during research scenarios focusing on episodes where symptoms become more noticeable.


Long-Term Research and Patterns of Use

For outcomes related to systemic or functional imbalance over months or years, the primary evidence is derived from long-term observational cohort studies. These studies evidence derived from settings with varying symptom burdens have studies monitored the use of this medication in real-world settings to understand how usage patterns was associated with outcomes related to systemic or functional imbalance over time. The data show patterns related to the recorded frequency of exacerbations and other outcomes related to physical discomfort observed in the studies, in patients whose recorded use of this type of medication was frequent or high. The long-term effects are not fully established through extensive RCTs spanning many years.


What Remains Uncertain and Research Gaps

The evidence highlights what is known — and what is still uncertain. The potential for a lessening of the expected response with repeated use is a pattern that was observed in some studies, and research is ongoing to better understand this response. Furthermore, the evidence quality varies across studies, and many early trials had sample sizes were modest, meaning the findings describe group patterns, not personal outcomes.

Key Studies & References Salbutamol in the Management of Asthma: A Review

Frequently Asked Questions (FAQ)

Common questions about Astagen (FAQ)

Q: Is it normal to feel tired when first starting Astagen?

Official product information, including drug labels, addresses potential effects on the Central Nervous System ( CNS) like dizziness and headache. While tiredness is not typically the most frequently listed reaction, these CNS effects may be associated with it. It is important that any new or concerning symptoms are discussed with a healthcare professional.

Q: How long does it typically take before I might notice the effects of Astagen?

Astagen is known as a short-acting medication designed for quick relief. For inhaled formulations, official documents indicate that the onset of action, or when the medicine begins working, is typically observed within mathbf5 to mathbf10 minutes after administration.

Q: If I miss a dose of Astagen, what is the generally recommended action?

Official patient leaflets suggest taking the missed dose as soon as it is noticed, if it is a regularly scheduled dose. However, the recommendation is to skip the missed dose if it is close to the next scheduled dose. Taking a double dose is generally not advised in official guidelines.

Q: Is Astagen safe to use for older adults (seniors)?

Regulatory documents advise that Astagen, like other beta-agonists, should be used with caution in the geriatric population (older adults). This is because seniors may be more susceptible to certain adverse effects, such as cardiovascular changes or tremor. Assessment by a healthcare provider is necessary to determine the individual risk and benefit.

Q: Is Astagen suitable for use by children or adolescents?

Yes, Astagen is indicated and approved for use in children and adolescents, often starting from mathbf4 years and older for inhaled forms, for the treatment of bronchospasm. The official dosing protocol for this population is procedural and weight-based, which reflects their faster drug clearance.

Q: Does Astagen interact with caffeine or alcohol?

Official regulatory warnings note potential interactions with alcohol. Although regulatory documents do not specifically list caffeine, caution is generally advised. As a CNS stimulant, caffeine may potentially add to or enhance some of the heart- or nervous system-related side effects of Astagen.

Q: Where can I find summaries of the clinical trials for Astagen?

Summaries of regulatory decisions, prescribing information, and clinical trial results are often made publicly available. You can typically find this information through official government resources such as mathbfDailyMed, mathbfMedlinePlus, or the government-run trial registry, mathbfClinicalTrials.gov.

Q: Is Astagen considered a long-term treatment option?

No. Astagen is classified as a mathbfShort-mathbfActing mathbfbetamathbf2-agonist (mathbfSABA). This classification indicates it is intended primarily for the acute, immediate relief of breathing symptoms (rescue use), rather than serving as a long-term, sustained maintenance treatment.

Q: What happens if Astagen is stopped suddenly?

Abruptly stopping the use of Astagen is generally not advised. Official resources indicate that sudden discontinuation could potentially lead to a worsening of the underlying respiratory condition. Any change to the medication regimen is a clinical decision that requires oversight from a healthcare professional.

Q: Why do official guidelines mention potential issues with Astagen and driving?

The warnings relate to potential side effects of the medication, such as mathbftremor, mathbfdizziness, mathbfheadache, or mathbfnervousness, all of which could potentially impair a person's ability to perform tasks like driving or operating machinery safely.

Q: Does Astagen affect sleep patterns?

Regulatory documents list potential effects on sleep. Both Insomnia (difficulty falling or staying asleep) and mathbfHyperactivity are noted as adverse reactions, typically categorized as uncommon to very rare.

Q: Is Astagen a controlled substance?

According to regulatory systems, such as the US Drug Enforcement Administration ( DEA) scheduling, Astagen (Albuterol/Salbutamol) is typically mathbfnot classified as a controlled substance.

Q: Can Astagen be taken by someone who is lactose intolerant?

Some formulations of Astagen, particularly certain dry powder inhalers ( DPIs), may contain mathbflactose as an inactive ingredient. Official documents suggest individuals with known intolerances review the inactive ingredients list with a healthcare professional.

Q: Why are people with a certain pre-existing condition advised not to use Astagen?

Contraindications and warnings exist because Astagen, as a beta-agonist, can cause mathbfclinically mathbfsignificant mathbfcardiovascular mathbfeffects, such as changes in heart rate and blood pressure. Consequently, the use of this medicine in patients with certain uncontrolled pre-existing conditions requires clinical management.

Q: What is the half-life of Astagen?

The half-life is a measure of how quickly a drug is eliminated from the body. Official Pharmacokinetic data indicates that the elimination half-life of the active ingredient varies depending on how the drug is administered, but typically ranges from approximately mathbf3.8 to mathbf6.5 hours.

Q: Does Astagen cause changes in mood or behavior?

Regulatory documents list CNS effects that relate to mood and behavior. Adverse reactions noted include common effects like mathbfnervousness and very rare effects such as mathbfhyperactivity. These are documented changes in behavior or feeling.

Q: Is Astagen known to cause any issues with vision or eyesight?

Visual disturbances are noted in official safety data. Adverse events such as mathbfblurred mathbfvision or other eyesight issues are documented as a rare occurrence, often associated with higher doses of the medication.

Q: Does Astagen contain any ingredients that might trigger a common allergy?

Yes, all drug formulations contain both active and inactive ingredients. Official documents state that hypersensitivity (allergic reaction) to mathbfany component, including the mathbfinactive mathbfingredients, is a mathbfcontraindication for use. The specific inactive ingredients are described in detail within the product label.

Q: How is Astagen processed and eliminated by the body?

Official Pharmacokinetic information describes how the body handles the drug. The active ingredient in Astagen is primarily mathbfmetabolized (broken down) in the mathbfliver into a non-active form. This inactive substance is then mathbfexcreted (eliminated) from the body mainly via the mathbfurine.

Q: What does 'contraindication' mean in the context of Astagen use?

A mathbfcontraindication is a regulatory term defined in official sources. It means the medication must not be used by patients who have a specific pre-existing medical condition, such as a known allergy to the drug. This means that the risks associated with taking the medicine in that specific situation clearly outweigh the potential benefits.

Q: Does Astagen affect fertility in men or women?

Official clinical and non-clinical research data has been evaluated regarding reproductive health. The evidence currently mathbfdoes mathbfnot mathbfindicate mathbfany mathbfadverse mathbfeffects on fertility in either males or females.

How should Astagen be stored and disposed of?

How to Store and Dispose of Astagen?

Astagen must be stored strictly according to the official requirements to maintain its stability and effectiveness.

Storage Requirement Official Regulatory Mandate
Temperature and Environment Store in a cool, dry place. Protect from heat and moisture.
Protection from Light Keep away from direct light.
Security Keep out of reach of children.
Packaging Keep the medicine in its original container.

Official disposal requirements specify that unused or expired Astagen must be discarded according to local environmental regulations. To prevent environmental contamination, do not flush the medicine down the toilet or pour it into a drain unless specifically instructed to do so by a healthcare professional or regulatory guideline.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Astagen found in:

A-Z Index: